Now comes Kirton and his advisory council’s most ambitious project, the virtual ALS Super Auction, between Feb. 6-20. Every ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal ...

The ALS Super Fund, a Charitable Impact Cause Fund led by former NHL player and ALS advocate Mark Kirton, is proud to announce the launch ...

Roy Woodlief, center, poses with Wake County Sheriff Donnie Harrison and Terry Putnam after Woodlief graduated the academy ...

The Valentine Plunge has raised nearly $5 million for the Joan Dancy and P.A.L.S. (People with ALS) Foundation.

LEXINGTON, Mass., Feb. 06, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will ...

Salt Lake City-based pharmaceutical company Clene Inc. has amended its grant subaward with Columbia University, securing up ...

Three patients with spinal muscular atrophy had improved muscle strength and could walk farther after a month of daily spinal stimulation.

Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...

A new platform for studying neuroinflammatory diseases, utilizing advanced 3D bioprinting technology was developed by POSTECH in collaboration with Seoul National University Hospital.

A patent has been granted in the US covering the use of Neurizon’s lead drug candidate NUZ-001 in neurodegenerative diseases ...

A retrospective analysis showed IV edaravone in participants with ALS was associated with fewer reported disease progression milestones and deaths than control.